Indonesia University: COVID-19 trials

The registry lists 16 COVID-19 studies with Indonesia University as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 3 2No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cognitive Function Analysis and qEEG Study in Long COVID-19 Syndrome PatientsRecruitingNCT05670418
• Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients RecoveryCompletedNCT06636760Not applicable
• Effectiveness of Modified Diaphragmatic Training for Gastroesophageal Reflux Disease Post Covid-19CompletedNCT05833243Not applicable
• Effect of Telerehabilitation Practice in Long COVID-19 PatientsStatus unknownNCT05817032Not applicable
• Effectiveness of Supportive Psychotherapy Through Internet-Based Teleconsultation on Psychological and Somatic Symptoms, Neutrophil-Lymphocyte Ratio, and Heart Rate Variability in Post Covid-19 Syndrome PatientsCompletedNCT05648123Not applicable
• COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 PatientsStatus unknownNCT05587868
• Thromboelastographic Methods in Deciding Therapy on Moderate to Severe COVID-19 PatientsCompletedNCT05343728
• Randomized Controlled Clinical Trial to Evaluate The Efficacy and Safety of Healthtone as Prophylaxis for COVID-19CompletedNCT05308615Not applicable
• Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19CompletedNCT05122234Phase 3
• In Situ Simulation Training in Transferring Critically Ill COVID-19 PatientsCompletedNCT05113823Not applicable
• Nutrition, Immunity, and Covid-19 in Obese PeopleCompletedNCT04979065Phase 2
• The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate SymptomsCompletedNCT04844710Not applicable
• Video-based Psychotherapy for COVID-19 Patients in Isolation Ward in JakartaCompletedNCT04841681Not applicable
• COVID-19, Aging, and Cardiometabolic Risk Factors StudyStatus unknownNCT04802044
• The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19Status unknownNCT04558463Phase 3
• Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 PatientsStatus unknownNCT04457609Phase 1